Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial

Robert J. Anderson, Gideon D. Bahn, Thomas E. Moritz, Derrick Kaufman, Carlos Abraira, William Duckworth

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

OBJECTIVE - Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CVD events in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS - Participants in the VADT (n = 1,791) with hypertension received stepped treatment to maintain blood pressure below the target of 130/80 mmHg in standard and intensive glycemic treatment groups. Blood pressure levels of all subjects at baseline and On-Study were analyzed to detect associations with CVD risk. The primary outcome was the time from randomization to the first occurrence of myocardial infarction, stroke, congestive heart failure, surgery for vascular disease, inoperable coronary disease, amputation for ischemic gangrene, or CVD death. RESULTS - Separated SBP ≥140 mmHg had significant risk at baseline (hazards ratio [HR] 1.508, P

Original languageEnglish
Pages (from-to)34-38
Number of pages5
JournalDiabetes Care
Volume34
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Hematologic Diseases
Veterans
Cardiovascular Diseases
Blood Pressure
Gangrene
Random Allocation
Vascular Diseases
Amputation
Type 2 Diabetes Mellitus
Thoracic Surgery
Coronary Disease
Research Design
Heart Failure

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Anderson, R. J., Bahn, G. D., Moritz, T. E., Kaufman, D., Abraira, C., & Duckworth, W. (2011). Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care, 34(1), 34-38. https://doi.org/10.2337/dc10-1420

Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. / Anderson, Robert J.; Bahn, Gideon D.; Moritz, Thomas E.; Kaufman, Derrick; Abraira, Carlos; Duckworth, William.

In: Diabetes Care, Vol. 34, No. 1, 01.2011, p. 34-38.

Research output: Contribution to journalArticle

Anderson, RJ, Bahn, GD, Moritz, TE, Kaufman, D, Abraira, C & Duckworth, W 2011, 'Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial', Diabetes Care, vol. 34, no. 1, pp. 34-38. https://doi.org/10.2337/dc10-1420
Anderson, Robert J. ; Bahn, Gideon D. ; Moritz, Thomas E. ; Kaufman, Derrick ; Abraira, Carlos ; Duckworth, William. / Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. In: Diabetes Care. 2011 ; Vol. 34, No. 1. pp. 34-38.
@article{b60f3f0685724f959c2f02a5a5b77b9d,
title = "Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial",
abstract = "OBJECTIVE - Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CVD events in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS - Participants in the VADT (n = 1,791) with hypertension received stepped treatment to maintain blood pressure below the target of 130/80 mmHg in standard and intensive glycemic treatment groups. Blood pressure levels of all subjects at baseline and On-Study were analyzed to detect associations with CVD risk. The primary outcome was the time from randomization to the first occurrence of myocardial infarction, stroke, congestive heart failure, surgery for vascular disease, inoperable coronary disease, amputation for ischemic gangrene, or CVD death. RESULTS - Separated SBP ≥140 mmHg had significant risk at baseline (hazards ratio [HR] 1.508, P",
author = "Anderson, {Robert J.} and Bahn, {Gideon D.} and Moritz, {Thomas E.} and Derrick Kaufman and Carlos Abraira and William Duckworth",
year = "2011",
month = "1",
doi = "10.2337/dc10-1420",
language = "English",
volume = "34",
pages = "34--38",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial

AU - Anderson, Robert J.

AU - Bahn, Gideon D.

AU - Moritz, Thomas E.

AU - Kaufman, Derrick

AU - Abraira, Carlos

AU - Duckworth, William

PY - 2011/1

Y1 - 2011/1

N2 - OBJECTIVE - Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CVD events in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS - Participants in the VADT (n = 1,791) with hypertension received stepped treatment to maintain blood pressure below the target of 130/80 mmHg in standard and intensive glycemic treatment groups. Blood pressure levels of all subjects at baseline and On-Study were analyzed to detect associations with CVD risk. The primary outcome was the time from randomization to the first occurrence of myocardial infarction, stroke, congestive heart failure, surgery for vascular disease, inoperable coronary disease, amputation for ischemic gangrene, or CVD death. RESULTS - Separated SBP ≥140 mmHg had significant risk at baseline (hazards ratio [HR] 1.508, P

AB - OBJECTIVE - Blood pressure ranges associated with cardiovascular disease (CVD) events in advanced type 2 diabetes are not clear. Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (DBP), and SBP combined with DBP predict CVD events in the Veterans Affairs Diabetes Trial (VADT). RESEARCH DESIGN AND METHODS - Participants in the VADT (n = 1,791) with hypertension received stepped treatment to maintain blood pressure below the target of 130/80 mmHg in standard and intensive glycemic treatment groups. Blood pressure levels of all subjects at baseline and On-Study were analyzed to detect associations with CVD risk. The primary outcome was the time from randomization to the first occurrence of myocardial infarction, stroke, congestive heart failure, surgery for vascular disease, inoperable coronary disease, amputation for ischemic gangrene, or CVD death. RESULTS - Separated SBP ≥140 mmHg had significant risk at baseline (hazards ratio [HR] 1.508, P

UR - http://www.scopus.com/inward/record.url?scp=79951713554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951713554&partnerID=8YFLogxK

U2 - 10.2337/dc10-1420

DO - 10.2337/dc10-1420

M3 - Article

C2 - 21059830

AN - SCOPUS:79951713554

VL - 34

SP - 34

EP - 38

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 1

ER -